Parallel regulation of extracellular ATP and inorganic pyrophosphate: Roles of growth factors, transduction modulators, and ANK

Objective. Extracellular inorganic pyrophosphate (ePPi) is a key regulator of pathologic mineralization in articular cartilage. Articular chondrocytes generate ePPi by the transportation of intracellular PPi (iPPi) through transport mechanisms such as ANK or by the degradation of extracellular adenosine triphosphate (eATP) by ectoenzymes. Although numerous modulators of ePPi have been characterized, little is known about eATP elaboration in cartilage. We sought to determine (1) whether eATP is coordinately regulated with ePPi and (2) whether ANK transports ATP. Methods. Primary articular chondrocytes were treated with factors known to modulate ePPi levels including growth factors (TGFβ1 and IGF-1), anion channel inhibitors, and chemicals that alter adenylyl cyclase and protein kinase C activities. Additional chondrocyte monolayers were infected with adenovirus containing functional (Ad-ANK) or mutated (Ad-ANK mutant) ANK sequences. eATP levels were measured with a bioluminescent assay. Results. TGFβ1 enhanced eATP accumulation by 33%, whereas IGF-1 decreased eATP accumulation by 63% and attenuated TGFβ1-induced eATP release by 72%. Forskolin and probenecid diminished eATP accumulation by 55% and 89%. Phorbol-12-myristate-13-acetate increased eATP by 29%. Transfection of chondrocytes with Ad-ANK caused a 10-fold increase in eATP compared with control values. Conclusion. Modulation of eATP by various factors paralleled their effects on ePPi production, suggesting a shared pathway of ePPi and eATP production and implicating ANK in eATP transport. As eATP directly contributes to pathologic mineralization in articular cartilage, understanding eATP regulation may lead to effective therapies for crystal-associated arthritis.

[1]  G. Dubyak,et al.  Autocrine ATP release coupled to extracellular pyrophosphate accumulation in vascular smooth muscle cells. , 2009, American journal of physiology. Cell physiology.

[2]  C. Poole,et al.  Articular chondrocytes express connexin 43 hemichannels and P2 receptors – a putative mechanoreceptor complex involving the primary cilium? , 2009, Journal of anatomy.

[3]  G. Dubyak Both sides now: multiple interactions of ATP with pannexin-1 hemichannels. Focus on "A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP". , 2009, American journal of physiology. Cell physiology.

[4]  C. Hirschmugl,et al.  Characterization of articular calcium-containing crystals by synchrotron FTIR. , 2008, Osteoarthritis and cartilage.

[5]  Keisuke Sawada,et al.  Identification of a vesicular nucleotide transporter , 2008, Proceedings of the National Academy of Sciences.

[6]  R. Sabirov,et al.  The maxi-anion channel: a classical channel playing novel roles through an unidentified molecular entity , 2008, The Journal of Physiological Sciences.

[7]  C. Gohr,et al.  Osteopontin promotes pathologic mineralization in articular cartilage. , 2007, Matrix biology : journal of the International Society for Matrix Biology.

[8]  H. Fleisch,et al.  The effect of pyrophosphate and diphosphonates on calcium transport in red cells , 1977, Experientia.

[9]  M. Kasper,et al.  Immunohistochemical distribution of connexin 43 in the cartilage of rats and mice , 1998, The Histochemical Journal.

[10]  D. Salter,et al.  ATP in the mechanotransduction pathway of normal human chondrocytes. , 2004, Biorheology.

[11]  M. Picher,et al.  Extracellular nucleotide metabolism and signaling in the pathophysiology of articular cartilage. , 2003, Arthritis and rheumatism.

[12]  R. Terkeltaub,et al.  Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification , 2003, Nature Genetics.

[13]  R. Busse,et al.  Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells. , 2003, American journal of physiology. Heart and circulatory physiology.

[14]  L. Ryan,et al.  Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease. , 2002, Arthritis and rheumatism.

[15]  R. Terkeltaub,et al.  Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Terkeltaub Inorganic pyrophosphate generation and disposition in pathophysiology. , 2001, American journal of physiology. Cell physiology.

[17]  D. Kingsley,et al.  Role of the mouse ank gene in control of tissue calcification and arthritis. , 2000, Science.

[18]  S. McMahon,et al.  ATP as a peripheral mediator of pain. , 2000, Journal of the autonomic nervous system.

[19]  G. Lee,et al.  ATP release by mechanically loaded porcine chondrons in pellet culture. , 2000, Arthritis and rheumatism.

[20]  R. Terkeltaub,et al.  Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes. , 1999, Arthritis and rheumatism.

[21]  H. Cheung,et al.  Transduction mechanisms of porcine chondrocyte inorganic pyrophosphate elaboration. , 1999, Arthritis and rheumatism.

[22]  C. Naus,et al.  Connexins regulate calcium signaling by controlling ATP release. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Yusuke Nakamura,et al.  Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine , 1998, Nature Genetics.

[24]  C. Rubin,et al.  Chondrocytes isolated from mature articular cartilage retain the capacity to form functional gap junctions , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  G. Cutting,et al.  CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP , 1995, Cell.

[26]  A. Rosenthal,et al.  Insulin-like growth factor-1 suppresses pyrophosphate elaboration by transforming growth factor beta1-stimulated chondrocytes and cartilage. , 1994, Osteoarthritis and cartilage.

[27]  A. Rosenthal,et al.  Probenecid inhibits transforming growth factor-beta 1 induced pyrophosphate elaboration by chondrocytes. , 1994, The Journal of rheumatology.

[28]  H. Cheung,et al.  A comparison of the effect of transforming growth factor beta 1 on pyrophosphate elaboration from various articular tissues. , 1993, Arthritis and rheumatism.

[29]  L. Ryan,et al.  ATP-induced chondrocalcinosis. , 1992, Arthritis and rheumatism.

[30]  A. Boskey,et al.  Articular cartilage vesicles generate calcium pyrophosphate dihydrate-like crystals in vitro. , 1992, Arthritis and rheumatism.

[31]  H. Cheung,et al.  Transforming growth factor beta 1 stimulates inorganic pyrophosphate elaboration by porcine cartilage. , 1991, Arthritis and rheumatism.

[32]  D. Mccarty,et al.  Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate. , 1991, The Journal of rheumatology.

[33]  D. Mccarty,et al.  Synovial fluid inorganic pyrophosphate concentration and nucleotide pyrophosphohydrolase activity in basic calcium phosphate deposition arthropathy and Milwaukee shoulder syndrome. , 1988, Arthritis and rheumatism.

[34]  L. Ryan,et al.  Adenosine triphosphate pyrophosphohydrolase and neutral inorganic pyrophosphatase in pathologic joint fluids. Elevated pyrophosphohydrolase in calcium pyrophosphate dihydrate crystal deposition disease. , 1985, Arthritis and rheumatism.

[35]  D. Mccarty,et al.  Cartilage nucleoside triphosphate pyrophosphohydrolase. II. Role in extracellular pyrophosphate generation and nucleotide metabolism. , 1985, Arthritis and rheumatism.

[36]  D. Mccarty,et al.  Cartilage Nucleoside Triphosphate (NTP) Pyrophosphohydrolase , 1984 .

[37]  D. Mccarty,et al.  Release of pyrophosphate by normal mammalian articular hyaline and fibrocartilage in organ culture. , 1981, Arthritis and rheumatism.

[38]  H. Cheung,et al.  A method for determining DNA and chondrocyte content of articular cartilage. , 1981, Analytical biochemistry.

[39]  R. Russell Metabolism of inorganic pyrophosphate (PPi). , 1976, Arthritis and rheumatism.